Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: A randomised trial

Additional Metadata
Persistent URL	doi.org/10.1016/S0140-6736(05)17701-0, hdl.handle.net/1765/57706
Journal	The Lancet
Organisation	Department of Pathology
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Janssen, H., van Zonneveld, M., Senturk, H., Zeuzem, S., Akarca, U., Cakaloglu, Y., … Schalm, S. (2005). Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: A randomised trial. The Lancet, 365(9454), 123–129. doi:10.1016/S0140-6736(05)17701-0

Publication